Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.2083 | 0.2083 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4168 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.5245 | 0.5245 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0537 | 0.1287 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.0247 | 0.0546 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.4168 | 1 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.0247 | 0.0592 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.2076 | 0.1417 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.035 | 0.035 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.4517 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1845 | 0.4427 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.0247 | 0.0592 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2314 | 0.2314 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.5663 | 0.5302 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.035 | 0.0774 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0537 | 0.1188 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.1845 | 0.4427 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0537 | 0.1287 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.006 | 0.006 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2501 | 0.2501 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 21.3313 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.